VASOPRESSIN is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Vasopressin, Unspecified.
| Product ID | 51662-1314_7ae1c8c9-7d76-55a8-e053-2991aa0af05b |
| NDC | 51662-1314 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VASOPRESSIN |
| Generic Name | Vasopressin |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-11-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204485 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | VASOPRESSIN, UNSPECIFIED |
| Active Ingredient Strength | 20 [USP'U]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-11-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204485 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-11-17 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-07 |
| Ingredient | Strength |
|---|---|
| VASOPRESSIN, UNSPECIFIED | 20 [USP'U]/mL |
| SPL SET ID: | 7ae1c8c9-7d75-55a8-e053-2991aa0af05b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0517-1020 | Vasopressin | Vasopressin |
| 0548-9701 | Vasopressin | Vasopressin |
| 42367-570 | VASOPRESSIN | VASOPRESSIN |
| 43598-085 | Vasopressin | Vasopressin |
| 51662-1314 | VASOPRESSIN | VASOPRESSIN |
| 51662-1607 | VASOPRESSIN | VASOPRESSIN |
| 52584-302 | VASOPRESSIN | vasopressin |
| 55150-370 | VASOPRESSIN | VASOPRESSIN |
| 55150-371 | Vasopressin | Vasopressin |
| 63323-302 | Vasopressin | VASOPRESSIN |
| 70121-1642 | vasopressin | vasopressin |
| 42023-164 | Vasostrict | Vasopressin |
| 42023-190 | Vasostrict | Vasopressin |
| 42023-219 | Vasostrict | Vasopressin |
| 42023-220 | Vasostrict | Vasopressin |
| 42023-237 | Vasostrict | Vasopressin |